Targeting MDR in breast and lung cancer: Discriminating its potential importance from the failure of drug resistance reversal studies

导出原文传递

翻译打印收藏纠错

作者： Amiri-Kordestani,L. ^[1] ; Basseville,A. ^[2] ; Kurdziel,K. ; Fojo,A.T. ; Bates,S.E.

作者单位： Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD ^[1] Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD ^[2]

关键词 18F fluoropaclitaxel 99mTc-sestamibi Breast cancer Drug penetration Lung cancer MDR-1/Pgp

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Drug resistance updates

2012年15卷1/2期

50-61页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Targeting MDR in breast and lung cancer: Discriminating its potential importance from the failure of drug resistance reversal studies

Drug resistance updates

相似文献

Drug resistance updates

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Targeting MDR in breast and lung cancer: Discriminating its potential importance from the failure of drug resistance reversal studies

Drug resistance updates

相似文献

Drug resistance updates

相关期刊

检索历史清除